Natera and Eledon partner on kidney transplant Phase 3 trial
Go back to Natera and Eledon partner on kidney transplant Phase 3 trial| (NASDAQ: ELDN) | Delayed: 3.58 -0.16 (4.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.74 | 52 Week High | $ | |||
| Open | $3.76 | 52 Week Low | $ | |||
| Day High | $3.76 | P/E | N/A | |||
| Day Low | $3.50 | EPS | $ | |||
| Volume | 1,280,438 | |||||
| (NASDAQ: NTRA) | Delayed: 261.99 -2.7 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $264.69 | 52 Week High | $13.80 | |||
| Open | $264.69 | 52 Week Low | $6.52 | |||
| Day High | $266.87 | P/E | N/A | |||
| Day Low | $260.27 | EPS | $0.00 | |||
| Volume | 699,449 | |||||
